Incretin-Based Drugs and Adverse Pancreatic Events: Almost a Decade Later and Uncertainty Remains

被引：22

作者：

Azoulay, Laurent ^{[1
,2
]}

机构：

[1] McGill Univ, Jewish Gen Hosp, Ctr Clin Epidemiol & Community Studies, Lady Davis Inst, Montreal, PQ H3T 1E2, Canada

[2] McGill Univ, Dept Oncol, Montreal, PQ, Canada

来源：

DIABETES CARE | 2015年 / 38卷 / 06期

关键词：

POPULATION-BASED COHORT; ANTIDIABETIC DRUGS; CLINICAL-USE; RISK; EXENATIDE; CANCER; THERAPIES; SITAGLIPTIN; INHIBITORS; METFORMIN;

D O I：

10.2337/dc15-0347

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

引用

页码：951 / 953

页数：3

共 24 条

[1]

Butler PC, 2013, DIABETES CARE, V36, P2118, DOI 10.2337/dc12-2713

[2]

Acute Pancreatitis in Patients with Type 2 Diabetes Mellitus Treated with Dipeptidyl Peptidase-4 Inhibitors: A Population-Based Nested Case-Control Study [J].

Chou, Hsin-Chun ;

Chen, Wen-Wen ;

Hsiao, Fei-Yuan .

DRUG SAFETY, 2014, 37 (07) :521-528

[3]

A cohort study of acute pancreatitis in relation to exenatide use [J].

Dore, D. D. ;

Bloomgren, G. L. ;

Wenten, M. ;

Hoffman, C. ;

Clifford, C. R. ;

Quinn, S. G. ;

Braun, D. K. ;

Noel, R. A. ;

Seeger, J. D. .

DIABETES OBESITY & METABOLISM, 2011, 13 (06) :559-566

[4]

Incidence of health insurance claims for thyroid neoplasm and pancreatic malignancy in association with exenatide: signal refinement using active safety surveillance [J].

Dore, David D. ;

Seeger, John D. ;

Chan, K. Arnold .

THERAPEUTIC ADVANCES IN DRUG SAFETY, 2012, 3 (04) :157-164

[5]

Use of a claims-based active drug safety surveillance system to assess the risk of acute pancreatitis with exenatide or sitagliptin compared to metformin or glyburide [J].

Dore, David D. ;

Seeger, John D. ;

Chan, K. Arnold .

CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (04) :1019-1027

[6]

Pancreatitis, Pancreatic, and Thyroid Cancer With Glucagon-Like Peptide-1-Based Therapies [J].

Elashoff, Michael ;

Matveyenko, Aleksey V. ;

Gier, Belinda ;

Elashoff, Robert ;

Butler, Peter C. .

GASTROENTEROLOGY, 2011, 141 (01) :150-156

[7]

Comparative safety and effectiveness of sitagliptin in patients with type 2 diabetes: retrospective population based cohort study [J].

Eurich, D. T. ;

Simpson, S. ;

Senthilselvan, A. ;

Asche, C. V. ;

Sandhu-Minhas, J. K. ;

McAlister, F. A. .

BMJ-BRITISH MEDICAL JOURNAL, 2013, 346

[8]

Pancreatitis associated with the use of GLP-1 analogs and DPP-4 inhibitors: a case/non-case study from the French Pharmacovigilance Database [J].

Faillie, Jean-Luc ;

Babai, Samy ;

Crepin, Sabrina ;

Bres, Virginie ;

Laroche, Marie-Laure ;

Le Louet, Herve ;

Petit, Pierre ;

Montastruc, Jean-Louis ;

Hillaire-Buys, Dominique .

ACTA DIABETOLOGICA, 2014, 51 (03) :491-497

[9]

Incretin based drugs and risk of acute pancreatitis in patients with type 2 diabetes: cohort study [J].

Faillie, Jean-Luc ;

Azoulay, Laurent ;

Patenaude, Valerie ;

Hillaire-Buys, Dominique ;

Suissa, Samy .

BMJ-BRITISH MEDICAL JOURNAL, 2014, 348

[10]

A prospective, claims-based assessment of the risk of pancreatitis and pancreatic cancer with liraglutide compared to other antidiabetic drugs [J].

Funch, D. ;

Gydesen, H. ;

Tornoe, K. ;

Major-Pedersen, A. ;

Chan, K. A. .

DIABETES OBESITY & METABOLISM, 2014, 16 (03) :273-275

← 1 2 3 →